CA Stock MarketDetailed Quotes

MRVL Marvel Biosciences Corp

Watchlist
  • 0.150
  • 0.0000.00%
15min DelayTrading Dec 12 10:46 ET
6.72MMarket Cap-3.75P/E (TTM)

Marvel Biosciences Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.46%-1.18M
23.57%-340.57K
-21.56%-359.98K
-0.72%-239.31K
32.10%-239.64K
39.28%-1.33M
-0.33%-445.56K
-37.19%-296.14K
81.14%-237.6K
-28.78%-352.93K
Net income from continuing operations
27.99%-1.65M
43.43%-591.65K
57.10%-307.31K
0.08%-232.81K
-74.98%-518.3K
10.29%-2.29M
-79.74%-1.05M
-82.61%-716.33K
78.22%-232.99K
41.94%-296.2K
Remuneration paid in stock
-5.49%75.72K
294.05%54.47K
-66.33%4.5K
-64.84%7.05K
-70.50%9.69K
--80.12K
--13.82K
--13.37K
--20.06K
--32.86K
Other non cashItems
--210K
----
----
----
----
----
----
----
----
----
Change In working capital
-78.97%184.86K
-102.25%-13.38K
-114.34%-57.17K
45.07%-13.55K
400.24%268.97K
144.14%879.04K
331.63%594.67K
125.95%398.63K
87.03%-24.67K
-137.94%-89.58K
-Change in receivables
116.63%4.24K
339.62%30.08K
25.05%-6.79K
30.06%-8.3K
-234.49%-10.76K
-1,054.87%-25.48K
-48.50%-12.55K
-137.43%-9.06K
79.33%-11.86K
-81.95%8K
-Change in prepaid assets
-114.78%-34.01K
-140.08%-46.05K
-91.88%10.7K
71.22%-7.43K
-4.16%8.76K
192.70%230.04K
147.70%114.9K
1,908.12%131.81K
---25.81K
--9.14K
-Change in payables and accrued expense
-68.18%214.64K
-99.48%2.58K
-122.14%-61.08K
-83.30%2.17K
353.88%270.96K
11.39%674.47K
27.19%492.32K
72.95%275.88K
109.79%13K
-155.64%-106.73K
Cash from discontinued investing activities
Operating cash flow
11.46%-1.18M
23.57%-340.57K
-21.56%-359.98K
-0.72%-239.31K
32.10%-239.64K
39.28%-1.33M
-0.33%-445.56K
-37.19%-296.14K
81.14%-237.6K
-28.78%-352.93K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-25.24%968.64K
468.64K
0
500K
0
228.85%1.3M
0
1M
0
295.65K
Net issuance payments of debt
-50.00%500K
--0
--0
----
----
--1M
--0
--1M
----
----
Net common stock issuance
85.19%500K
1,766.67%500K
--0
--0
--0
-35.71%270K
-107.14%-30K
--0
--0
--300K
Net other financing activities
-222.25%-31.36K
----
----
----
----
198.65%25.65K
--30K
--0
--0
---4.35K
Cash from discontinued financing activities
Financing cash flow
-25.24%968.64K
--468.64K
--0
--500K
--0
228.85%1.3M
--0
--1M
--0
--295.65K
Net cash flow
Beginning cash position
-6.17%556.62K
-78.28%217.69K
93.64%577.67K
-40.85%316.98K
-6.17%556.62K
-75.21%593.21K
55.78%1M
-65.28%298.33K
-74.71%535.93K
-75.21%593.21K
Current changes in cash
-476.34%-210.85K
128.75%128.08K
-151.14%-359.98K
209.72%260.69K
-318.37%-239.64K
97.97%-36.59K
-789.12%-445.56K
426.08%703.86K
81.14%-237.6K
79.10%-57.28K
End cash Position
-37.88%345.77K
-37.88%345.77K
-78.28%217.69K
93.64%577.67K
-40.85%316.98K
-6.17%556.62K
-6.17%556.62K
55.78%1M
-65.28%298.33K
-74.71%535.93K
Free cash from
11.46%-1.18M
23.57%-340.57K
-21.56%-359.98K
-0.72%-239.31K
32.10%-239.64K
39.28%-1.33M
-0.33%-445.56K
-37.19%-296.14K
81.14%-237.6K
-28.78%-352.93K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.46%-1.18M23.57%-340.57K-21.56%-359.98K-0.72%-239.31K32.10%-239.64K39.28%-1.33M-0.33%-445.56K-37.19%-296.14K81.14%-237.6K-28.78%-352.93K
Net income from continuing operations 27.99%-1.65M43.43%-591.65K57.10%-307.31K0.08%-232.81K-74.98%-518.3K10.29%-2.29M-79.74%-1.05M-82.61%-716.33K78.22%-232.99K41.94%-296.2K
Remuneration paid in stock -5.49%75.72K294.05%54.47K-66.33%4.5K-64.84%7.05K-70.50%9.69K--80.12K--13.82K--13.37K--20.06K--32.86K
Other non cashItems --210K------------------------------------
Change In working capital -78.97%184.86K-102.25%-13.38K-114.34%-57.17K45.07%-13.55K400.24%268.97K144.14%879.04K331.63%594.67K125.95%398.63K87.03%-24.67K-137.94%-89.58K
-Change in receivables 116.63%4.24K339.62%30.08K25.05%-6.79K30.06%-8.3K-234.49%-10.76K-1,054.87%-25.48K-48.50%-12.55K-137.43%-9.06K79.33%-11.86K-81.95%8K
-Change in prepaid assets -114.78%-34.01K-140.08%-46.05K-91.88%10.7K71.22%-7.43K-4.16%8.76K192.70%230.04K147.70%114.9K1,908.12%131.81K---25.81K--9.14K
-Change in payables and accrued expense -68.18%214.64K-99.48%2.58K-122.14%-61.08K-83.30%2.17K353.88%270.96K11.39%674.47K27.19%492.32K72.95%275.88K109.79%13K-155.64%-106.73K
Cash from discontinued investing activities
Operating cash flow 11.46%-1.18M23.57%-340.57K-21.56%-359.98K-0.72%-239.31K32.10%-239.64K39.28%-1.33M-0.33%-445.56K-37.19%-296.14K81.14%-237.6K-28.78%-352.93K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -25.24%968.64K468.64K0500K0228.85%1.3M01M0295.65K
Net issuance payments of debt -50.00%500K--0--0----------1M--0--1M--------
Net common stock issuance 85.19%500K1,766.67%500K--0--0--0-35.71%270K-107.14%-30K--0--0--300K
Net other financing activities -222.25%-31.36K----------------198.65%25.65K--30K--0--0---4.35K
Cash from discontinued financing activities
Financing cash flow -25.24%968.64K--468.64K--0--500K--0228.85%1.3M--0--1M--0--295.65K
Net cash flow
Beginning cash position -6.17%556.62K-78.28%217.69K93.64%577.67K-40.85%316.98K-6.17%556.62K-75.21%593.21K55.78%1M-65.28%298.33K-74.71%535.93K-75.21%593.21K
Current changes in cash -476.34%-210.85K128.75%128.08K-151.14%-359.98K209.72%260.69K-318.37%-239.64K97.97%-36.59K-789.12%-445.56K426.08%703.86K81.14%-237.6K79.10%-57.28K
End cash Position -37.88%345.77K-37.88%345.77K-78.28%217.69K93.64%577.67K-40.85%316.98K-6.17%556.62K-6.17%556.62K55.78%1M-65.28%298.33K-74.71%535.93K
Free cash from 11.46%-1.18M23.57%-340.57K-21.56%-359.98K-0.72%-239.31K32.10%-239.64K39.28%-1.33M-0.33%-445.56K-37.19%-296.14K81.14%-237.6K-28.78%-352.93K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data